CONTENTS
Ⅰ General Report
1 The Development and Influence of the New Mode of Pharmaceutical Distribution/Circulation
【Xiao Hanshan, Yang Yehui and Wang Lin】／001
1. Pharmaceutical Online Retailers will Reshape the Two Terminal Circulation of Hospitals
and Pharmacies／002
2. Supply Chain Finance will Redistribute the Interest of All Parties／007
3. Pharmacy Trusteeship will Expand the Control of Circulation Enterprises on the Downstream
under the Situation of Medication Retail Separating from Hospital／010
4. Big Data Shortens the Distance between the Pharmaceutical Circulation Industry Chain
Enterprises／012
5. The Rise of Pharmaceutical Online Retailers will Change the CompetitiveLandscape of
Traditional Medicine Distribution.／013
6. Investment Targets／021
Ⅱ Industry Reports
2 Statistical Analysis Report of Pharmaceutical Circulation Industry in 2014
【Ministry of Commerce of the People’s Republic of China Department of Market Supervision】／022
3 The Adjustment and Introduction of Regulatory Laws, Regulations and Major Policies of
China Drugs and Medical Equipments in 2014【Tang Minhao, Chen Ji and Ye Hua】／036
4 Drug Utilization of Insured Hospitalized Patients with the Basic Medical Insurance of Cities
and Towns【Xiong Xianjun, Zhang Jie and Li Jinghu】／046
5 Ton output Capacity,Out-side-hospital Nirvana: Establish Outside Hospital Supply System of
China Chronic Disease Drugs【Fang Zhiwu】／059
6 The Policy , Platform and Effects of Drug E-commerce【Gao Congshan】／072
Ⅲ Special Investigation Reports
7 Actively Implement “Notice about the Implementation of 2014 Key Tasks of Medical Reform
Focus on Improving the Circulation Service Level and Efficiency of the Work”Issued
by the Ministry of Commerce and Other 6 Departments
【Research Group of China Pharmaceutical Business Association】／082
8 The Investigation Report on the Modernization of Pharmaceutical Logistics in Pharmaceutical
Circulation Industry【Research Group of China Pharmaceutical Business Association】／087
9 The Cost Test for the Temperature Sensitive Drug Logistics and Research Report【The joint
Research Group of China Pharmaceutical Business Association and Beijing Wuzi University】／106
Ⅳ District Reports
10 The Review on the Development of Pharmaceutical Circulation Industry of Beijing in 2014
【Beijing Medical Association】／147
11 Shanghai Pharmaceutical Circulation Market has Achieved Rapid and Robust Development
Driven by Health Care Reform【Cao Weirong】／157
12 The Development Analysis of Pharmaceutical Circulation Industry in Jiangsu Province
in 2014【Lu Wenqing】／164
13 The Operation Analysis of the Pharmaceutical Circulation Industry of Sichuan Province
in 2014【Sichuan Pharmaceutical Business Association】／174
Ⅴ Chinese Drug Retail Reports
14 The Analysis of China’s Overall Drug Retail Market in 2014
【China Association of Pharmaceutical Commerce】／189
15 Innovate and Upgrade Business Structure to Achieve Leap-type Development:National
Pharmacy has been the Leader of Pharmaceutical Retail Industry in Health
【National Pharmacy Holdings Limited company】／221
16 Regional Focusing and Robust Expansion: The Characteristic Operation Mode of Yifeng
Pharmacy【Yifeng Pharmacy chain Limited by Share Ltd】／227
17 Innovation Development with the Times:The Development Road of ShuyuPingmin
Pharmacy【Ji’nanShuyuPingmin pharmacy Co. Ltd.】／233
Ⅵ The Development Reports
18 The Operation Analysis of the Listed Corporation in Pharmaceutical Circulation Industry
in 2014【Li Wenming】／239
19 The Interest Distribution Mode of Pharmaceutical Circulation
【Xiao Hanshan, Yang Yehui and Wang Lin】／249
20 The Construction and Development of the Supply Chain cloud Service Platform for
the National Medicine Holding SAVE【The SAVE Project Group of National
Pharmaceutical Cmi Holdings Ltd.】／261
21 The Practice and Achievements of the E-commerce in the Pharmaceutical Business of
JoinTown Pharmaceutical Group【JoinTown Pharmaceutical Group Co. Ltd.】／279
22 The Participation of Social Logistics in the Field of Pharmaceutical Circulation and the
Analysis of the Factors Affecting the Quality of Medical Logistics【Tao Chen】／283
23 Smart Health Ecosystem with the Trend of Mobile Internet【Fu Gang】／297
Ⅶ Cases
24 Focusing Service and Innovation:The Characteristic Development Mode of Shanghai
Pharmaceutical Group Limited by Share Ltd. Commercial
【Shanghai Pharmaceutical Group Limited by Share Ltd. Commercial】／304
25 Service Transition is the Only Way for Pharmaceutical Business Development:
Guangzhou Medicines Co. Determines to become the Best Service Providers
of Medicine Supply Chain【Guangzhou Pharmaceutical Co.Ltd.】／312
26 Serve the Public Health and Develop Wisdom Economy: East China Pharmaceutical
Devotes to the Big Health Industry【East China Pharmaceutical Limited by Share Ltd.】／321
27 The Successful Way of Connotation Growth and Extension Development
【Zhejiang Intel group Limited by Share Ltd.】／327
Ⅷ Appendix
28 Statistics and Tables on Pharmaceutical Market
【China Association of Pharmaceutical Commerce】／335
This book is the annual blue book of pharmaceutical distribution industry. Based on the Annual Report on China’s Pharmaceutical Distribution Industry (2014), this book distributes to several big chapters to focus on the analyzing and researching with the relevant issues of pharmaceutical circulation industry. The general report studies the development of the new mode of pharmaceutical distribution and its effects. It also includes the development and influences of pharmaceutical online retailers, the influences of supply chain finance and medication retail partially separates from hospital. The general report also analysis the relationship between the development of big data and pharmaceutical distribution and the influences of the e-commerce of pharmaceutical on the competitive landscape of traditional medicine distribution. Compare with Report (2014), this general report is more focused on the disruptive innovation brought by new pharmaceutical distribution mode, instead of focusing on the effects of traditional health care reform.
京公网安备 11010202010375号 新出网证（京）字094号
